BioHarvest Sciences Inc. Common Stock (BHST) Revenue History
Annual and quarterly revenue from 2013 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
BHST Revenue Growth
Revenue Breakdown (FY 2024)
BHST's revenue distribution by segment and geography for fiscal year 2024
By Product/Segment
By Geography
BHST Revenue Analysis (2013–2024)
As of May 7, 2026, BioHarvest Sciences Inc. Common Stock (BHST) generated trailing twelve-month (TTM) revenue of $32.7 million, reflecting explosive growth of +38.7% year-over-year. The most recent quarter (Q3 2025) recorded $9.1 million in revenue, up 6.5% sequentially.
Looking at the longer-term picture, BHST's 5-year compound annual growth rate (CAGR) stands at +158.6%, indicating outstanding long-term growth trajectory. The company achieved its highest annual revenue of $25.2 million in 2024, representing a new all-time high.
Revenue diversification analysis shows BHST's business is primarily driven by Total (50%), and Products (50%). With over half of revenue concentrated in Total, the company maintains significant focus in this area while developing other growth vectors.
When compared to Basic Materials sector peers including NXRT (-0.7% YoY), GFAI (+4.0% YoY), and SIGA (-31.8% YoY), BHST has outperformed the peer group in terms of revenue growth. Compare BHST vs NXRT →
BHST Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| BHSTCurrent | $33M | +38.7% | +158.6% | -27.7% | |
 NXRT | $251M | -0.7% | +4.2% | 11.1% | |
 GFAI | $36M | +4.0% | -1.2% | -18.5% | |
 SIGA | $95M | -31.8% | -5.4% | 25.1% | |
 XTLB | $451,000 | - | - | -481.6% | |
 LWAY | $212M | +13.7% | +15.8% | 7.6% |
BHST Historical Revenue Data (2013–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $25.2M | +98.8% | $13.9M | 55.4% | $-6,989,000 | -27.7% |
| 2023 | $12.7M | +130.5% | $5.6M | 44.5% | $-9,966,000 | -78.6% |
| 2022 | $5.5M | +161.6% | $1.2M | 22.2% | $-10,612,000 | -193.0% |
| 2021 | $2.1M | +430.8% | $670K | 31.9% | $-8,491,000 | -403.9% |
| 2020 | $396K | +81.7% | $138K | 34.8% | $-6,166,000 | -1557.1% |
| 2019 | $218K | - | $29K | 13.3% | $-2,310,000 | -1059.6% |
| 2018 | $0 | - | $0 | - | $-4,355,000 | - |
| 2017 | $0 | - | $0 | - | $0 | - |
| 2016 | $0 | - | $0 | - | $-93,081 | - |
| 2015 | $0 | - | $0 | - | $-127,743 | - |
See BHST's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs BHST Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare BHST vs LIN
Side-by-side business, growth, and profitability comparison vs Linde plc.
Start ComparisonBHST — Frequently Asked Questions
Quick answers to the most common questions about buying BHST stock.
Is BHST's revenue growth accelerating or slowing?
BHST revenue is accelerating at +38.7% year-over-year, exceeding the 5-year CAGR of +158.6%. TTM revenue reached $33M. Growth momentum has increased versus prior periods.
What is BHST's long-term revenue growth rate?
BioHarvest Sciences Inc. Common Stock's 5-year revenue CAGR of +158.6% reflects the sustained expansion pattern. Current YoY growth of +38.7% is above this long-term average.
How is BHST's revenue distributed by segment?
BHST reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2013-2024 are available for download. Segment mix reveals concentration and diversification trends.